Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2021-08-19 00:00:00 ET · period of report 2021-08-18 · accession 0001708138-21-000062 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2021-08-19 | 2021-04-01+ | REGN | VAGELOS P ROY | Dir | G - Gift | $0.00 | -819 | 142.0K | -0.6% | $0 |
| I | 2021-08-19 | 2021-08-18 | REGN | VAGELOS P ROY | Dir | S - Sale | $650.04 | -10.0K | 37.7K | -21% | -$6.53M |
| M | 2021-08-19 | 2021-05-27+ | REGN | VAGELOS P ROY | Dir | G - Gift | $0.00 | -58.0K | 308.1K | -16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-04-01 | G | D | 446 | $0.00 | 142,350 | I | — | — | |
| 2 | Common | Common Stock | 2021-08-18 | S | D | 10,039 | $650.04 | 37,747 | I | — | — | (F2) Represents volume-weighted average price of sales of 10,039 shares of Company stock on August 18, 2021 at prices ranging from $650.00 to $650.31. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 18, 2021 at each separate price. |
| 3 | Common | Common Stock | 2021-07-02 | G | D | 373 | $0.00 | 141,977 | I | — | — | |
| 4 | Common | Common Stock | 2021-08-09 | G | D | 17,000 | $0.00 | 291,090 | D by Spouse as Trustee | — | — | |
| 5 | Common | Common Stock | 2021-05-27 | G | D | 22,000 | $0.00 | 327,090 | D by CLAT | — | — | |
| 6 | Common | Common Stock | 2021-06-14 | G | D | 19,000 | $0.00 | 308,090 | D by CLAT | — | — |